Latest News for: taiho

Edit

Devil Taiho

Bitchute 05 Jul 2024
Go to the source via the article link to view the video or lcik the video icon ....
Edit

Metastatic Colorectal Cancer Pipeline 2024 | Pfizer, Sanofi, Taiho Pharma, Ono Pharma, Hutchison Medipharma, Isofol ...

GetNews 30 Apr 2024
Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with many others, there are several emerging key players which are expected to change the Metastatic ...
Edit

Sumo: Takerufuji ties Taiho's top-tier rookie win streak record of 11

Kyodo 20 Mar 2024
... on Wednesday, matching the record for a top-tier makuuchi division debutant's perfect start from the first day set in January 1960 by former yokozuna Taiho.
Edit

Taiho Oncology Announces Publication of Final Results of the Phase 3 ASCERTAIN Clinical Trial of ...

Victoria Advocate 23 Jan 2024
23, 2024 /PRNewswire/ -- Taiho Oncology, Inc ... and Canada is conducted by Taiho Oncology, Inc. and Taiho Pharma Canada, Inc., respectively.
Edit

Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation

Victoria Advocate 08 Jan 2024
8, 2024 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd ... Taiho Pharmaceutical and Taiho Ventures are committed to sustainable delivery of new technologies and treatment options to patients in need. About Taiho Pharmaceutical Co., Ltd.
Edit

Taiho Oncology Announces Presentation of Data From a U.S. Real-Word Study of Oral Decitabine and Cedazuridine

Victoria Advocate 10 Dec 2023
10, 2023 /PRNewswire/ -- Taiho Oncology, Inc ... About Taiho Oncology, Inc. The mission of Taiho Oncology, Inc ... Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd ... Taiho Oncology Contact.
Edit

Taiho Oncology Announces Publication of Final Results of the Phase 3 ASCERTAIN Clinical Trial of Oral Decitabine and Cedazuridine Fixed Dose Combination (INQOVI®) in Patients With MDS and CMML

PR Newswire 22 Nov 2023
23, 2024 /PRNewswire/ -- Taiho Oncology, Inc ... and Canada is conducted by Taiho Oncology, Inc. and Taiho Pharma Canada, Inc., respectively ... Taiho Oncology, the Taiho Oncology logo and INQOVI are registered trademarks of Otsuka Holdings Co., Ltd.
Edit

Taiho Oncology And Astex Pharmaceuticals Announce Data Presentations At The 65Th ASH Annual Meeting

MENA FN 17 Nov 2023
(MENAFN - PR Newswire) (PRNewsfoto/Taiho Oncology, Inc.). (PRNewsfoto/Taiho Oncology, Inc.) Real-world evidence on use of oral decitabine and cedazuridine in the treatment of ... .
Edit

Araris Biotech AG Announces Research Collaboration With Taiho Pharmaceutical To Develop Next-Generation Adcs Using Araris' ...

MENA FN 08 Nov 2023
(MENAFN - GlobeNewsWire - Nasdaq) AU ZH, Switzerland, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG (–Araris–), a Swiss oncology biotech company developing next-generation antibody drug ... .
Edit

Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate LYTGOBI® (futibatinib) in Combination with BBI-355 in Patients with FGFR Amplified Solid Tumors

Pharmiweb 18 Sep 2023
(Taiho) for Taiho’s pan-FGFR inhibitor LYTGOBI® (futibatinib) for use in combination with BBI-355 in a clinical trial of patients with locally advanced or metastatic solid tumors with oncogene amplifications.

Most Viewed

×